Sana Biotechnology raises $69M through sale of 21.6M shares in ATM offering

Filed May 15, 2026 · Period ending May 15, 2026 · ~1 min read

Key Changes

• high

  Company sold 21.6 million shares of common stock for net proceeds of approximately $69 million through its at-the-market offering program with TD Securities as sales agent.

  8-K: ATM equity offering verify on EDGAR →
• high

  The share sale dilutes existing shareholders by increasing outstanding share count by approximately 21.6 million shares, but provides capital to fund ongoing operations and development programs.

  8-K: ATM equity offering verify on EDGAR →